(Q34435115)

2 August 2017

1 reference

title

Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism (English)

1 reference

2 August 2017

1 reference

Catalano M

1

1 reference

PubMed ID

11704420

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

European Neuropsychopharmacology

2 August 2017

1 reference

2 August 2017

11

1 reference

2 August 2017

6

1 reference

2 August 2017

431-439

1 reference

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to tridimensional personality questionnaire persistence scores in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Orphan receptors, novel neuropeptides and reverse pharmaceutical research

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Ethnicity and antipsychotic response

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Role of the serotonin transporter gene in temperament and character

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

COMT andDRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Initiation and adaptation: a paradigm for understanding psychotropic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Initial sequencing and analysis of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Pharmacogenetics and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Neuroleptic malignant syndrome and hydroxylase gene mutations: no association with CYP2D6A or CYP2D6B

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Transmission-ratio distortion of X chromosomes among male offspring of females with skewed X-inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

The medical utility of genomics data in neuropsychiatry: mutational genetics versus association genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Artificial neural networks: a study in clinical psychopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Late‐Onset psychosis in the velo‐cardio‐facial syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Panic and phobic anxiety: defining phenotypes for genetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Recent progress in psychiatric genetics-some hope but no hype

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Brain elimination half-life of fluvoxamine measured by 19F magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Over the mainstream: diagnostic requirements for biological psychiatric research

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Black and white patients response to antidepressant treatment for major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Lack of evidence for association between the COMT locus and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

Expression and characterization of a dopamine D4R variant associated with delusional disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900120-1

7 January 2021

10.1016/S0924-977X(01)00120-1

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11704420